Loading...

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.

Adriamycin and cyclophosphamide are active agents in human and experimental tumours. Using the L1210 murine leukaemia, their effectiveness alone and in combination was studied. The combination is highly synergistic in this tumour, resulting in a greater than 50% survival rate when the agents used al...

Full description

Saved in:
Bibliographic Details
Main Authors: Tobias, J. S., Parker, L. M., Tattersall, M. H., Frei, E.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 1975
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2024893/
https://ncbi.nlm.nih.gov/pubmed/1212350
Tags: Add Tag
No Tags, Be the first to tag this record!